Workflow
CytoMed Therapeutics (GDTC) - 2025 Q2 - Quarterly Report

Exhibit 99.1 CYTOMED THERAPEUTICS LIMITED AND SUBSIDIARIES UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INDEX | Page | | | --- | --- | | Unaudited Interim Condensed Consolidated Statements of Profit or Loss and Other Comprehensive Loss for the Six months | | | ended June 30, 2024 and 2025 | 1 | | Unaudited Interim Condensed Consolidated Statements of Financial Positions as of December 31, 2024 and June 30, 2025 | 2 | | Unaudited Interim Condensed Consolidated Statements of Cash Flows for th ...